IBSA Derma, IBSA’s Aesthetic Medicine Division, expands its Profhilo injectable treatments line with what it claims is one of the highest concentrations of high molecular weight hyaluronic acid on the market. The solution comprises stable hybrid cooperative complexes composed of high- and low-molecular-weight hyaluronic acid, stabilized by a patented thermal process without using any chemical agent.
